Benjamin Demoulin

Biologist with strong expertise in Cancer research, Cancer immunology, cell therapies (CAR-T, CAR NK, hiPSC, allo, auto) & ADC. Currently Preclinical Director at ATB therapeutics focusing on developing Antibody Toxin fused bodies (ATB's) for clinic.

He said : I'm delighted to support LiveDrop and the Modaflow development. This company will make droplet microfluidics and functional cell sorting accessible to all!

‍

‍